6 days Wall Street Analysts Predict a 75.79% Upside in Rigel (RIGL): Here’s What You Should Know Zacks X
1 week Xenon Pharmaceuticals: 2025 Could Be Pivotal For Azetukalner’s Epilepsy Potential Seeking Alpha X
1 week Recursion Pharmaceuticals (RXRX) Rises Yet Lags Behind Market: Some Facts Worth Knowing Zacks X
1 week Rocket Pharmaceuticals (RCKT) Loses -12.5% in 4 Weeks, Here’s Why a Trend Reversal May be Around the Corner Zacks X
1 week Down -9.11% in 4 Weeks, Here’s Why Tarsus Pharmaceuticals (TARS) Looks Ripe for a Turnaround Zacks X
1 week Regeneron Pharmaceuticals, Inc. (REGN) 43rd Annual J.P. Morgan Healthcare Conference 2025 (Transcript) Seeking Alpha X
1 week Vertex Pharmaceuticals Incorporated (VRTX) CEO Reshma Kewalramani Hosts 43rd Annual J.P. Morgan Healthcare Conference (Transcript) Seeking Alpha X
2 weeks Does Recursion Pharmaceuticals (RXRX) Have the Potential to Rally 27.96% as Wall Street Analysts Expect? Zacks X
2 weeks Zentalis Pharmaceuticals (ZNTL) Upgraded to Strong Buy: What Does It Mean for the Stock? Zacks X
2 weeks West Pharmaceuticals: Cannot Wrap My Head Around Valuations (Rating Downgrade) Seeking Alpha X
2 weeks Alnylam Pharmaceuticals: Commercialization And Early-Stage Studies Are Likely To Drive 2025 Seeking Alpha X
2 weeks Vertex Pharmaceuticals (VRTX) Stock Drops Despite Market Gains: Important Facts to Note Zacks X
3 weeks Biodexa Pharmaceuticals PLC Unsponsored ADR (BDRX) Moves to Buy: Rationale Behind the Upgrade Zacks X
3 weeks Vertex Pharmaceuticals Incorporated (VRTX) is Attracting Investor Attention: Here is What You Should Know Zacks X
3 weeks Vertex Pharmaceuticals (VRTX) Advances While Market Declines: Some Information for Investors Zacks X
3 weeks Vertex Pharmaceuticals: Jim Cramer Fires A Warning Shot But I Remain Invested Seeking Alpha X
4 weeks How Tarsus Pharmaceuticals’ Unique Inspiration Is Driving A Triple-Digit Run Investor's Business Daily X
4 weeks The Zacks Analyst Blog Highlights ADMA Biologics, Tarsus Pharmaceuticals, Stoke Therapeutics, Inc. and ChromaDex Zacks X
4 weeks The Zacks Analyst Blog Highlights T-Mobile, Toyota Motor, Vertex Pharmaceuticals, BK Technologies and Servotronics Zacks X
1 month Vertex Wins An Early Approval; Why It Might Not Move Vertex’s Beleaguered Stock Investor's Business Daily X
1 month Rhythm Pharmaceuticals’ Obesity Treatments Target Less Crowded Space, Analyst Sees Long-Term Potential Yahoo Finance X
1 month Vertex Non-Opioid Drug Doesn’t Best Placebo In Back Pain Study. The Stock Is Plunging. Investor's Business Daily X
1 month Vertex Pharmaceuticals Incorporated (VRTX) Is a Trending Stock: Facts to Know Before Betting on It Zacks X
Stock Market News